WALTHAM, Mass. (Feb. 11, 2022) – Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, today announced that Chief Financial Officer John Strumbos will participate in the virtual 11th Annual SVB Leerink...
Patient Response to Treatment 3x Better When PrismRA Guided Therapy Selection Test Results Informed Treatment Decisions for Three-Quarters of Patients Broad Adoption Could Lead to Significant Clinical Improvements for Rheumatoid Arthritis Patients WALTHAM, Mass. (Feb....
WALTHAM, Mass. (Jan. 6, 2022) - Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, today announced that Alif Saleh, chief executive officer, will present at the 40th Annual J.P. Morgan...
PrismRA enables precision medicine, supports better outcomes, and reduces ineffective utilization of TNFi therapy for rheumatoid arthritis treatment WALTHAM, Mass. (December 6, 2021) – Scipher Medicine, a precision immunology company matching patients with their most...
